Klinefelter综合征患者精原细胞年龄相关存在的系统综述与荟萃分析
该系统综述与荟萃分析纳入36篇文献共386例Klinefelter综合征患者,评估不同年龄组睾丸活检中精原细胞的存在率。胎儿/婴儿组全部存在,青春期前组83%,围青春期组42.7%,成人组48.5%存在精原细胞。围青春期和成人组中无精子症患者分别有46.4%和24.3%精原细胞阳性,部分激素水平与精原细胞存在相关。
要点
- Klinefelter综合征患者各年龄组均可检出精原细胞,成人组约48.5%阳性。
- 围青春期和成人无精子症患者中分别有46.4%和24.3%精原细胞阳性。
- 围青春期精原细胞阳性者FSH和LH较低、睾酮较高,抑制素B无差异。
核心结论
- 尽管无精子症常见,许多Klinefelter综合征患者睾丸中仍存在精原细胞。
- 精原细胞体外扩增、移植和分化技术为这些患者保留生育力提供了新途径。
研究设计与样本
- 系统综述与荟萃分析,检索Medline/PubMed从1965年10月1日至2019年2月3日。
- 最终纳入36篇文献,共386例Klinefelter综合征患者,证据级别IV-VI。
主要发现
- 围青春期组56例无精子症患者中26例(46.4%)精原细胞阳性,成人组152例中37例(24.3%)阳性(P < 0.05)。
- 围青春期精原细胞阳性组FSH均值12.88 ± 3.13 IU/L,阴性组30.42 ± 4.05 IU/L(P = 0.001)。
- 围青春期精原细胞阳性组LH均值4.36 ± 1.31 IU/L,阴性组11.43 ± 1.68 IU/L(P < 0.01)。
- 成人组精原细胞阳性者FSH均值25.77 ± 2.78 IU/L,阴性组36.12 ± 2.90 IU/L(P < 0.05)。
关键数值与推荐
- 围青春期精原细胞阳性与阴性组睾酮均值分别为5.04 ± 1.37和9.05 ± 0.94 nmol/L(P < 0.05)。
- 围青春期抑制素B在两组间差异无统计学意义(P > 0.05)。
临床怎么用
- 对Klinefelter综合征无精子症患者,睾丸活检可能发现精原细胞,为生育力保存提供机会。
- 围青春期FSH、LH和睾酮水平可能辅助预测精原细胞存在,但需谨慎解读。
局限性
- 纳入研究多为病例报告、病例对照系列和队列研究,证据级别IV-VI。
- 缺乏足够把握度的数据,激素作为生物标志物的效用需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Klinefelter syndrome (KS) has been defined by sex chromosome aneuploidies (classically 47, XXY) in the male patient. The peripubertal timeframe in KS patients has been associated with the initiation of progressive testicular fibrosis, loss of spermatogonial stem cells (SSC), hypogonadism and impaired fertility. Less than half of KS patients are positive for spermatozoa in the ejaculate or testis via semen analysis or testicular sperm extraction, respectively. However, the chance of finding spermatogonia including a sub-population of SSCs in KS testes has not been well defined. Given the recent demonstration of successful cell culture for mouse and human SSCs, it could be feasible to isolate and propagate SSCs and transplant the cells back to the patient or to differentiate them in vitro to haploid cells. OBJECTIVE AND RATIONALE: The main objective of this study was to meta-analyse the currently available data from KS patients to identify the prevalence of KS patients with spermatogonia on testicular biopsy across four age groups (year): fetal/infantile (age ≤ 1), prepubertal (age 1 ≤ x ≤ 10), peripubertal/adolescent (age 10 < x < 18) and adult (age ≥ 18) ages. Additionally, the association of endocrine parameters with presence or absence of spermatogonia was tested to obtain a more powered analysis of whether FSH, LH, testosterone and inhibin B can serve as predictive markers for successful spermatogonia retrieval. SEARCH METHODS: A thorough Medline/PubMed search was conducted using the following search terms: 'Klinefelter, germ cells, spermatogenesis and spermatogonia', yielding results from 1 October 1965 to 3 February 2019. Relevant articles were added from the bibliographies of selected articles. Exclusion criteria included non-English language, abstracts only, non-human data and review papers. OUTCOMES: A total of 751 papers were identified with independent review returning 36 papers with relevant information for meta-analysis on 386 patients. For the most part, articles were case reports, case-controlled series and cohort studies (level IV-VI evidence). Spermatogonial cells were present in all of the fetal/infantile and 83% of the prepubertal patients' testes, and in 42.7% and 48.5% of the peripubertal and adult groups, respectively were positive for spermatogonia. Additionally, 26 of the 56 (46.4%) peripubertal/adolescent and 37 of the 152 (24.3%) adult patients negative for spermatozoa were positive for spermatogonia (P < 0.05). In peripubertal/adolescent patients, the mean ± SEM level for FSH was 12.88 ± 3.13 IU/L for spermatogonia positive patients and 30.42 ± 4.05 IU/L for spermatogonia negative patients (P = 0.001); the mean ± SEM level LH levels were 4.36 ± 1.31 and 11.43 ± 1.68 IU/L for spermatogonia positive and negative, respectively (P < 0.01); the mean ± SEM level for testosterone levels were 5.04 ± 1.37 and 9.05 ± 0.94 nmol/L (equal to 145 ± 40 and 261 ± 27 and ng/dl) for the spermatogonia positive and negative groups, respectively (P < 0.05), while the difference in means for inhibin B was not statistically significant (P > 0.05). A similar analysis in the adult group showed the FSH levels in spermatogonia positive and negative patients to be 25.77 ± 2.78 and 36.12 ± 2.90 IU/L, respectively (mean ± SEM level, P < 0.05). All other hormone measurements were not statistically significantly different between groups. WIDER IMPLICATIONS: While azoospermia is a common finding in the KS patient population, many patients are positive for spermatogonia. Recent advances in SSC in vitro propagation, transplantation and differentiation open new avenues for these patients for fertility preservation. This would offer a new subset of KS patients a chance of biological paternity. Data surrounding the hormonal profiles of KS patients and their relation to fertility should be interpreted with caution as a paucity of adequately powered data exists. Future work is needed to clarify the utility of FSH, LH, testosterone and inhibin B as biomarkers for successful retrieval of spermatogonia.
引用
- Deebel NA, Galdon G, Zarandi NP, et al. Age-related presence of spermatogonia in patients with Klinefelter syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2020. PMID: 31822886. doi:10.1093/humupd/dmz038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。